KLIFO A/S: Financial statements 2013
CVR: 18196131
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
KLIFO A/S (CVR 18196131) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 16,819,053 and a net result of DKK 2,140,492 compared with DKK 393,117 the year before. That is an increase of 22.6% compared with the year before. Equity in the 2013 report amounted to DKK 5,038,418. The solvency ratio was 42.6%.
- Gross Profit
- DKK 16,819,053
- Profit/Loss
- DKK 2,140,492
- Equity
- DKK 5,038,418
- Total Assets
- DKK 11,832,838
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 16.8 mio. | 2.1 mio. | 5 mio. | - |
| 2012 | - | 13.7 mio. | 393 t. | 3.1 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
KLIFO A/S has published its annual report for 2012. Gross profit came to DKK 13,713,586, and the net result was DKK 393,117.
About KLIFO A/S
KLIFO A/S is a Danish company of the type Aktieselskab based in Brøndby, founded in 1994. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of René Holmen Pedersen. The board consists of Niels Peder Nielsen (chair), Alejandra Maria Cristina Bonifacini Mørk, Rafael Natanek and Redmar Koene. The company is owned by Drug Development Consulting BidCo ApS. The company has 114 employees (2026). In 2025, the company reported a gross profit of DKK 84,066,000 and a net result of DKK -47,419,000 compared with DKK -128,000 the year before. Equity in the 2025 report amounted to DKK 16,135,000.